Skip to Main Content

Author Details

Daniel Leongamornlert
Oncogenetics Team The Institute of Cancer Research London UK.
2003
66
41
PMIDPaper TitleJournal TitlePublished Year
37025481Serum testosterone and prostate cancer in men with germline <i>BRCA1/2</i> pathogenic variants.BJUI Compass2023
34657128Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.Leukemia2022
35941135Unified classification and risk-stratification in Acute Myeloid Leukemia.Nat Commun2022
35953478Clonal diversification and histogenesis of malignant germ cell tumours.Nat Commun2022
35948631Diverse mutational landscapes in human lymphocytes.Nature2022
34788984Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.Haematologica2022
33054126<i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).Haematologica2021
33767199Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.Nat Commun2021
34646017Convergent somatic mutations in metabolism genes in chronic liver disease.Nature2021
34433962The mutational landscape of human somatic and germline cells.Nature2021
34477813IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.Blood Adv2021
32317634Timing the initiation of multiple myeloma.Nat Commun2020
32087150Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.Mol Ther2020
33392515Revealing the impact of structural variants in multiple myeloma.Blood Cancer Discov2020
32350471The mutational landscape of normal human endometrial epithelium.Nature2020
30622367Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.Nat Genet2019
31346173Author Correction: A practical guide for mutational signature analysis in hematological malignancies.Nat Commun2019
31278357A practical guide for mutational signature analysis in hematological malignancies.Nat Commun2019
31444325Genomic landscape and chronological reconstruction of driver events in multiple myeloma.Nat Commun2019
30777372Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.Eur Urol2019
30837682Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.Br J Cancer2019
30829413Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.Am J Hematol2019
29301143Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.Br J Cancer2018
29892050Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.Nat Commun2018
29892016Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.Nat Genet2018
29915322Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.Br J Cancer2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29438362Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.Br J Cancer2018
29509747Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.Br J Cancer2018
26964030Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.Br J Cancer2016
26589274LocusExplorer: a user-friendly tool for integrated visualization of human genetic association data and biological annotations.Bioinformatics2016
27262462Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.Hum Genet2016
25595936Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.Ann Oncol2015
26347108High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers.Ann Oncol2015
25837820Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.Cancer Epidemiol Biomarkers Prev2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
26025378Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.Hum Mol Genet2015
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25454609Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.Eur Urol2015
24489760Telomere length shows no association with BRCA1 and BRCA2 mutation status.PLoS One2014
25217961A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.Nat Genet2014
25145435Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond.Future Oncol2014
24556621Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.Br J Cancer2014
24550738Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.PLoS Genet2014
23065704A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.Hum Mol Genet2013
23535732Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.Nat Genet2013
23569316Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.J Clin Oncol2013
23320731Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.BJU Int2013
22516946Germline BRCA1 mutations increase prostate cancer risk.Br J Cancer2012
21465221Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript.Hum Genet2011
  • 1 - 50 of 66

Recommended Authors

Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 3
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 9
Veronica Y Sabelnykova
Ontario Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 7
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 21
Xiaoyu Wang
Fred Hutchison Cancer Center
Career Start Year 2015
Number of shared co-authors 7
Matthew H Bailey
Department of Biology at Brigham Young University
Career Start Year 2013
Number of shared co-authors 3
Aurelie Vogt
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 12
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 27
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 18
Emilie Lalonde
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 13
Paul Lloyd
Bluestar Genomics Inc.
Career Start Year 2010
Number of shared co-authors 3
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 7
Alessandro Romanel
University of Trento
Career Start Year 2008
Number of shared co-authors 3
Alexander W Wyatt
University of British Columbia
Career Start Year 2007
Number of shared co-authors 14
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 53
Sigve Nakken
University of Oslo
Career Start Year 2007
Number of shared co-authors 15
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 29
Robert C Onofrio
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 29
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 18
Mine S Cicek
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 23
Joachim Weischenfeldt
University of Copenhagen
Career Start Year 2004
Number of shared co-authors 21
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 2
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 13
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 19
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 15
Liang Wang
H. Lee Moffitt Cancer Center
Career Start Year 1996
Number of shared co-authors 18
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 28
Clare Turnbull
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 54
Heather Thorne
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 22
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 17

Collaborators

Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 42
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 42
Douglas F Easton
University of Cambridge
Co-authored papers 30
Tokhir Dadaev
The Institute of Cancer Research
Co-authored papers 29
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 26
Freddie C Hamdy
University of Oxford
Co-authored papers 22
Graham G Giles
Co-authored papers 19
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 16
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 15
Stephen N Thibodeau
Mayo Clinic
Co-authored papers 15
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 15
Christopher A Haiman
University of Southern California
Co-authored papers 15
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 15
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 13
Judith A Clements
Co-authored papers 12
Daniel J Schaid
Mayo Clinic
Co-authored papers 12
Børge G Nordestgaard
Co-authored papers 12
Brian E Henderson
University of Southern California
Co-authored papers 11
Elaine A Ostrander
National Cancer Institute
Co-authored papers 11
Fredrik Wiklund
Co-authored papers 11
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 11
Ruth C Travis
Co-authored papers 11
Sue A Ingles
Co-authored papers 11
Shannon K McDonnell
Mayo Clinic
Co-authored papers 11
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 10
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 10
Fredrick R Schumacher
Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Co-authored papers 10
Chris Ogden
The Royal Marsden Hospital NHS Foundation Trust
Co-authored papers 10
Esther M John
Co-authored papers 10
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 10
Release 1.2